CD8A and neoplasm: On day 14, the frequency of TAS CD8+ T cells was higher in the intrahepatic TILs compared to subcutaneous TILs, whereas no significant differences in tumor weights between intrahepatic and subcutaneous CT26 tumors were found at this time point, ruling out the contribution of tumor burden (Fig. 1B, C).